Compare FPS & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FPS | RDY |
|---|---|---|
| Founded | 2023 | 1984 |
| Country | United States | India |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 9.9B |
| IPO Year | 2026 | 2001 |
| Metric | FPS | RDY |
|---|---|---|
| Price | $33.10 | $12.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $42.63 | $16.90 |
| AVG Volume (30 Days) | ★ 6.9M | 2.9M |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 0.52% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $74.33 | $7.72 |
| Revenue Next Year | $43.11 | $3.50 |
| P/E Ratio | $526.99 | ★ $18.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.27 | $11.36 |
| 52 Week High | $66.00 | $15.67 |
| Indicator | FPS | RDY |
|---|---|---|
| Relative Strength Index (RSI) | 36.96 | 44.06 |
| Support Level | $28.14 | $11.47 |
| Resistance Level | $37.10 | $12.58 |
| Average True Range (ATR) | 2.10 | 0.20 |
| MACD | 0.05 | 0.06 |
| Stochastic Oscillator | 7.08 | 59.50 |
Forgent Power Solutions Inc designs and manufactures electrical distribution equipment for data centers, the power grid, and industrial facilities. Its offerings include automatic transfer switches, transformers (dry type and liquid filled), electrical houses, generator connection cabinets, panelboards, switchboards, switchgear, power distribution units, power skids, remote power panels, and tap boxes.It specializes in manufacturing Custom Products and Powertrain Solutions for technically demanding applications, including data center power distribution, utility substations and energy-intensive manufacturing. The majority of the company's revenue is derived from custom products designed for specific projects with significant engineering consultation.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.